What is the price-to-earnings ratio of 3SBio?
The price-earnings ratio of 3SBio is currently 7.28.
3SBio P/E 2024
3SBio P/E
7.28
Ticker
1530.HK
ISIN
KYG8875G1029
WKN
A14T7Q
As of Sep 28, 2024, 3SBio's P/E ratio was 7.28, a -34.41% change from the 11.1 P/E ratio recorded in the previous year.
The 3SBio P/E history
3SBio Aktienanalyse
What does 3SBio do?
3SBio Inc. is a biopharmaceutical company from China that specializes in the research, development, manufacturing, and marketing of biological products. It was founded in 1993 in Shenyang, a city in northeast China, and its headquarters are now in Beijing. 3SBio's business model is based on the development and manufacturing of biopharmaceuticals that are used to treat cancer, autoimmune diseases, and other serious illnesses. The company focuses on biological medicines such as proteins, antibodies, and peptides that are produced using genetic technology. 3SBio operates a wide range of business sectors, including the manufacturing and sale of biopharmaceutical products, the manufacturing and sale of generics and biosimilar products, and research and development in the biotechnology field. The company also has several subsidiaries and joint ventures, including 3SBio International Holding, Sunshine Guojian Pharmaceutical, and Target Pharma. A well-known product of 3SBio is erythropoietin (EPO), which is used in the treatment of anemia. The company also has a portfolio of other biopharmaceutical products that are used to treat cancer, autoimmune diseases, and other serious illnesses. The history of 3SBio goes back to 1993 when it was founded as Shenyang Sunshine Pharmaceutical. In 2001, the company was renamed "Shenyang Sunshine Pharmaceutical Co. Ltd. 3S Bio" and focused on biological therapy. In 2007, the company successfully listed on the Hong Kong Stock Exchange and received the name 3SBio. In 2013, the company was privatized and acquired by a consortium of Chinese investment companies. 3SBio has a strong presence in China and is also expanding into international markets. The company has distribution partnerships in Asia, Europe, and North America, and plans to enter more markets. Overall, 3SBio is a leading company in China in the field of biopharmaceuticals that focuses on the treatment of serious illnesses. The company aims to be a leader in research and development, as well as in the manufacturing and sale of innovative products, and to expand its presence in global markets. 3SBio ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/E Details
Deciphering 3SBio's P/E Ratio
The Price to Earnings (P/E) Ratio of 3SBio is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.
Year-to-Year Comparison
Assessing 3SBio's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.
Impact on Investments
The P/E ratio of 3SBio is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.
Interpreting P/E Ratio Fluctuations
Fluctuations in 3SBio’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.
Frequently Asked Questions about 3SBio stock
How has the price-earnings ratio of 3SBio changed compared to last year?
The price-to-earnings ratio of 3SBio has increased by -34.41% fallen (meaning "decreased" or "dropped") compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of 3SBio high compared to other companies?
Yes, the price-to-earnings ratio of 3SBio is high compared to other companies.
How does an increase in the price-earnings ratio of 3SBio affect the company?
An increase in the price-earnings ratio of 3SBio would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of 3SBio affect the company?
A decrease in the price-earnings ratio of 3SBio would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of 3SBio?
Some factors that influence the price-earnings ratio of 3SBio are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does 3SBio pay?
Over the past 12 months, 3SBio paid a dividend of 0.1 CNY . This corresponds to a dividend yield of about 1.73 %. For the coming 12 months, 3SBio is expected to pay a dividend of 0.11 CNY.
What is the dividend yield of 3SBio?
The current dividend yield of 3SBio is 1.73 %.
When does 3SBio pay dividends?
3SBio pays a quarterly dividend. This is distributed in the months of July, July, July, August.
How secure is the dividend of 3SBio?
3SBio paid dividends every year for the past 0 years.
What is the dividend of 3SBio?
For the upcoming 12 months, dividends amounting to 0.11 CNY are expected. This corresponds to a dividend yield of 1.92 %.
In which sector is 3SBio located?
3SBio is assigned to the 'Health' sector.
Wann musste ich die Aktien von 3SBio kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of 3SBio from 8/5/2024 amounting to 0.25 CNY, you needed to have the stock in your portfolio before the ex-date on 7/22/2024.
When did 3SBio pay the last dividend?
The last dividend was paid out on 8/5/2024.
What was the dividend of 3SBio in the year 2023?
In the year 2023, 3SBio distributed 0.2 CNY as dividends.
In which currency does 3SBio pay out the dividend?
The dividends of 3SBio are distributed in CNY.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von 3SBio
Our stock analysis for 3SBio Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of 3SBio Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
